Responsibilities:
• Design and execute companion diagnostic development strategy for oncology programs.
• Closely follow industry and regulatory trends related to companion diagnostic product development.
• Work closely with cross-functional teams to design and execute biomarker-driven clinical trials.
• Lead the development and validation of biomarker assays for clinical use, including proficiency testing, analytical validation, and clinical validation.
• Contact and oversee diagnostic reagent companies with central lab service and CDx development service capabilities
• Participate in the preparation of regulatory submissions related to biomarkers and the communication with regulatory authorities.
• Evaluate new technologies to implement in clinical studies to address emerging biomarker questions.
Qualifications:
• Ph.D or MD in molecular biology, or related discipline with 5+ years of industrial experience working in translational research or IVD/CDx development.
• Strong knowledge of various biomarker platforms (such as IHC, flow cytometry, NGS, Luminex, QPCR, etc.) and their clinical practice.
• Experience of companion diagnostic development and assays validation in drug development is preferred.
• Ability to multitask across multiple development assets and to work in a fast-paced, dynamic environment. Work in a flexible schedule to meet deadlines.
• Proven ability to frame issues, ask the right clarifying questions, and rationalize decisions.
• Good interpersonal and coordination skills.
• Good written and oral language skills in English and Mandarin Chinese